CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
Clicks: 344
ID: 121799
2016
Cancer is caused by a series of alterations in genome and epigenome mostly resulting in activation of oncogenes or inactivation of cancer suppressor genes. Genetic engineering has become pivotal in the treatment of cancer and other genetic diseases, especially the formerly-niche use of clustered reg …
| Reference Key |
fa2016oncotargetcrispr/cas9
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Khan FA;Pandupuspitasari NS;Chun-Jie H;Ao Z;Jamal M;Zohaib A;Khan FA;Hakim MR;ShuJun Z;; |
| Journal | oncotarget |
| Year | 2016 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
genetic diseases
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
faheem ahmed khan
neoplasms / therapy*
clustered regularly interspaced short palindromic repeats*
genetic therapy / methods*
nuruliarizki shinta pandupuspitasari
pmid:27250031
pmc5239572
doi:10.18632/oncotarget.9646
zhang shujun
inborn / therapy*
genetic engineering / methods
genetic engineering / trends
genetic therapy / trends*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.